GLP-1 receptor agonists
US$ 23.02
lemd tirzepatide Compounded Tirzepatide Tier 1 - Lumos
Description
Trusted by thousands of patients, this personalized treatment is designed to deliver lasting results tailored to your unique health needs, empowering you to achieve and maintain a healthier lifestyle
Patients with GI sensitivity: While orforglipron's GI side effect profile is broadly similar to injectable GLP-1s, the daily oral dosing means the GI tract is exposed to the active compound on a different kinetic schedule than weekly injections
Most agents have shown good tolerability
Journal of Clinical Endocrinology & Metabolism, 91(9), 3854-3859
